This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Anticoagulation prior to cardioversion of atrial fibrillation (AF)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Cardioversion of atrial fibrillation (AF) carries a moderate risk of thromboembolism in patients who have been in AF for more than 2 days.

In people with atrial fibrillation in whom the duration of the arrhythmia is greater than 48 hours or uncertain and considered for long-term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a minimum of 3 weeks. During this period offer rate control as appropriate

Reference:

  1. NICE (April 2021). Atrial Fibrillation.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.